✦ LIBER ✦

Imatinib (STI571; GleevecR) — a new approach in the treatment of biliary tract cancer?

✍ Scribed by Wiedmann, Marcus W.; Mossner, Joachim; Caca, Karel

Book ID: 121905750
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 250 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)83892-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new NMR-based metabolomics approach fo

A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer

✍ He Wen; Sung Soo Yoo; Jinho Kang; Hee Goo Kim; Jin-Seok Park; Seok Jeong; Jung I 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 674 KB

Intelligent drug design come of age: STI

Intelligent drug design come of age: STI571 as the start a of a new era in cancer research and treatment

✍ Juan Carlos Lacal 📂 Article 📅 2001 🏛 Springer Milan 🌐 Spanish ⚖ 26 KB

New advances in the management of biliar

New advances in the management of biliary tract cancer

✍ JOHN BRIDGEWATER; CHARLES IMBER 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

Percutaneous Approach to the Diagnosis a

Percutaneous Approach to the Diagnosis and Treatment of Biliary Tract Malignancies

✍ Garcia, Mark J.; Epstein, David S.; Dignazio, Michael A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Adjuvant Therapy in the Treatment of Bil

Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis

✍ Horgan, A. M.; Amir, E.; Walter, T.; Knox, J. J. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 167 KB

A trial of glucagon in the treatment of

A trial of glucagon in the treatment of painful biliary tract disease

✍ M. J. Stower; G. E. Foster; J. D. Hardcastle 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

## Abstract Seventy-one patients with a clinical diagnosis of painful biliary tract disease have been entered into a double-blind trial of glucagon. Twenty-eight were excluded as gallstones were not proved: of the remainder, 21 patients received glucagon and 22 placebo. Glucagon-treated patients we